Literature DB >> 2548333

Structural and functional characterization of mutants of the bovine leukemia virus transactivator protein p34.

L Willems1, G Chen, D Portetelle, R Mamoun, A Burny, R Kettmann.   

Abstract

Mutants of the bovine leukemia virus (BLV) transactivator protein (tat, tax, p34, the XLOR gene product) were constructed by site-directed deletions, in-phase linker insertions, or fragment replacements (swapping) among BLV variants. The mutant constructs were transfected into cos cells and transiently expressed. Western blot analysis using a mixture of monoclonal antibodies to wild-type p34 revealed the presence of mutated XLOR gene products in all the mutants tested. The transactivating activity of 11 tax mutants containing site-directed deletions and in-phase linker insertions was completely abolished. Only the swapping mutant tested, a hybrid between two BLV variants, transactivated LTR-directed gene expression at wild-type levels. These data illustrate the narrow range of structural variations that allow full activity of the BLV tax product and suggest that the present molecular structure of the transactivator protein results from heavy evolutionary constraints.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2548333     DOI: 10.1016/0042-6822(89)90633-8

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  8 in total

1.  Mutations in the bovine leukemia virus Tax protein can abrogate the long terminal repeat-directed transactivating activity without concomitant loss of transforming potential.

Authors:  L Willems; C Grimonpont; H Heremans; N Rebeyrotte; G Chen; D Portetelle; A Burny; R Kettmann
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

Review 2.  Factors controlling the expression of mouse mammary tumour virus.

Authors:  W H Günzburg; B Salmons
Journal:  Biochem J       Date:  1992-05-01       Impact factor: 3.857

3.  Serum response factor has functional roles both in indirect binding to the CArG box and in the transcriptional activation function of human T-cell leukemia virus type I Tax.

Authors:  M Fujii; H Tsuchiya; T Chuhjo; T Minamino; K Miyamoto; M Seiki
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

4.  Both wild-type and strongly attenuated bovine leukemia viruses protect peripheral blood mononuclear cells from apoptosis.

Authors:  F Dequiedt; E Hanon; P Kerkhofs; P P Pastoret; D Portetelle; A Burny; R Kettmann; L Willems
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

5.  The region between amino acids 245 and 265 of the bovine leukemia virus (BLV) tax protein restricts transactivation not only via the BLV enhancer but also via other retrovirus enhancers.

Authors:  S Tajima; Y Aida
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

6.  In vivo rescue of a silent tax-deficient bovine leukemia virus from a tumor-derived ovine B-cell line by recombination with a retrovirally transduced wild-type tax gene.

Authors:  A Van Den Broeke; C Bagnis; M Ciesiolka; Y Cleuter; H Gelderblom; P Kerkhofs; P Griebel; P Mannoni; A Burny
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

7.  Cooperation between bovine leukaemia virus transactivator protein and Ha-ras oncogene product in cellular transformation.

Authors:  L Willems; H Heremans; G Chen; D Portetelle; A Billiau; A Burny; R Kettmann
Journal:  EMBO J       Date:  1990-05       Impact factor: 11.598

Review 8.  Mechanisms of leukemogenesis induced by bovine leukemia virus: prospects for novel anti-retroviral therapies in human.

Authors:  Nicolas Gillet; Arnaud Florins; Mathieu Boxus; Catherine Burteau; Annamaria Nigro; Fabian Vandermeers; Hervé Balon; Amel-Baya Bouzar; Julien Defoiche; Arsène Burny; Michal Reichert; Richard Kettmann; Luc Willems
Journal:  Retrovirology       Date:  2007-03-16       Impact factor: 4.602

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.